Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 16 articles: HTML format

Single Articles

December 2025
1. HUA K, Jin J, Zhao J, Song J, et al
   [Expression of Concern] miR?135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
   Int J Oncol. 2025;67:96.
   PubMed     Abstract available
   
   
   November 2025
2. ZOU X, Li S, Huang S, Niu R, et al
   Harnessing TP73?targeted nintedanib: A novel strategy to halt triple?negative breast cancer via p53?PPARalpha/PI3K?Akt pathway suppression.
   Int J Oncol. 2025;67:88.
   PubMed     Abstract available
   
   
   
3. HUANG X, Luo W, Liu W, Liu X, et al
   Progerin regulates actin cytoskeletal remodeling and inhibits EMT and metastasis in triple?negative breast cancer cells.
   Int J Oncol. 2025;67:92.
   PubMed     Abstract available
   
   
   August 2025
4. KAUSAR MA, Alshammari KF, Alenazi F, Anwar S, et al
   RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).
   Int J Oncol. 2025;67:65.
   PubMed     Abstract available
   
   
   
5. CHUNG SS, Giehl N, Wu Y, Vadgama JV, et al
   [Corrigendum] STAT3 activation in HER2?overexpressing breast cancer promotes epithelial?mesenchymal transition and cancer stem cell traits.
   Int J Oncol. 2025;67:69.
   PubMed     Abstract available
   
   
   July 2025
6. PARK AY, Kim JH, Lee S, Kim HS, et al
   Impact of PD?L1 upregulation on immune checkpoint inhibitor efficacy in triple?negative breast cancer using a 4T1 murine model.
   Int J Oncol. 2025;67:54.
   PubMed     Abstract available
   
   
   June 2025
7. ZHANG X, Zhao X, Shao S, Zuo X, et al
   [Retracted] Notch1 induces epithelial?mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
   Int J Oncol. 2025;66:46.
   PubMed     Abstract available
   
   
   
8. KIM ES
   Molecular targets and therapies associated with poor prognosis of triple?negative breast cancer (Review).
   Int J Oncol. 2025;66:52.
   PubMed     Abstract available
   
   
   May 2025
9. SUN MX, Zhu HC, Yu Y, Yao Y, et al
   Role of the Wnt signaling pathway in the complex microenvironment of breast cancer and prospects for therapeutic potential (Review).
   Int J Oncol. 2025;66:36.
   PubMed     Abstract available
   
   
   
10. GIL EY, Jo UH, Jeong H, Whang YM, et al
    [Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule?targeting agent docetaxel in breast cancer.
    Int J Oncol. 2025;66:39.
    PubMed     Abstract available
    
    
    January 2025
11. LEE WX, Yeo BS, Mahmud R, Tan GC, et al
    MicroRNAs and their role in breast cancer metabolism (Review).
    Int J Oncol. 2025;66:7.
    PubMed     Abstract available
    
    
    October 2024
12. SOLEK J, Braun M, Sadej R, Romanska HM, et al
    FGFR?related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review).
    Int J Oncol. 2024;65:94.
    PubMed     Abstract available
    
    
    September 2024
13. YANG Y, Gao F, Ren L, Ren N, et al
    Functions and mechanisms of RNA m(6)A regulators in breast cancer (Review).
    Int J Oncol. 2024;65:86.
    PubMed     Abstract available
    
    
    
14. FU Z, Song P, Li D, Yi C, et al
    [Corrigendum] Cancer?associated fibroblasts from invasive breast cancer have an attenuated capacity to secrete collagens.
    Int J Oncol. 2024;65:87.
    PubMed     Abstract available
    
    
    May 2024
15. AI L, Yi N, Qiu C, Huang W, et al
    Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review).
    Int J Oncol. 2024;64:46.
    PubMed     Abstract available
    
    
    April 2024
16. MBUGUA RW, Takano A, Tsevegjav B, Yokose T, et al
    Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.
    Int J Oncol. 2024;64:43.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.